Medtronic (MDT) Sinks 6% on Disappointing Earnings and Guidance as Macro Issues Weigh, Analyst Warns Issues Might Not Resolve 'Near Term'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Medtronic, Inc. (MDT) PT Lowered to $111 at Truist Securities
May 27, 2022 8:09 AM EDTTruist Securities analyst Richard Newitter lowered the price target on Medtronic, Inc. (NYSE: MDT) to $111.00 (from $121.00) while maintaining a Hold rating following earnings.
The analyst commented, "We stay at HOLD following MDT's disappointing F4Q & below CNS F1Q/FY23 guide. We appreciate MDT's... More
Medtronic, Inc. (MDT) PT Lowered to $117 at Cowen; FY23 Can Be a Year of Real Pipeline Progress
May 27, 2022 6:21 AM EDTCowen analyst Joshua Jennings lowered the price target on Medtronic, Inc. (NYSE: MDT) to $117.00 (from $125.00) while maintaining an Outperform rating following earnings. Despite weak guidance, the analyst said FY23 can be a year of real pipeline progress.
The analyst commented, "MDT delivered... More
Medtronic, Inc. (MDT) PT Lowered to $125 at Stifel
May 27, 2022 6:13 AM EDTStifel analyst Rick Wise lowered the price target on Medtronic, Inc. (NYSE: MDT) to $125.00 (from $128.00) while maintaining a Buy rating.
The analyst commented, "Yes. We had hoped that Medtronics F4Q22 (Apr.) would show more visibly-positive signs of CEO Geoff Marthas positive... More
